Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Pfizer Inc.

Complete the combination of Mylan N.V. and Upjohn Inc

Delivered after the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
19 Dec 2019
Due
30 Jun 2020
Delivered
by 16 Nov 2020
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“completion of the planned combination of Mylan N.V. and Upjohn Inc., which is expected to occur in mid-2020.”

What we found

Evidence strength A What the grades mean

The combination of Upjohn and Mylan was not completed by mid-2020; it was finalized in November 2020 after receiving necessary regulatory approvals.

  • A
    Pfizer Inc. 10-Q filed 2020-08-06 Regulatory filing · published 6 Aug 2020 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint f26dae1a4b72
    “Financial guidance for Total Company reflects a full-year 2020 contribution from Biopharma and Upjohn, the current construct of the company, and excludes any impact from the pending Upjohn combination with Mylan.” ✓ confirmed on the page

Market reaction: the shares moved -1.2% against the S&P 500 over the three sessions around the disclosure (5 Aug 2020 to 10 Aug 2020). What this measures

Checked 1 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Transaction other
Indicative materiality
Medium rules
Action
Complete
Deliverable
combination of Mylan N.V. and Upjohn Inc.
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: receipt of approval of Mylan’s shareholders; regulatory approvals
Depends on
Regulatory, Shareholder

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Not met”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Pfizer Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2019-PFE-001718 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.